Precision Optics Corporation (POCI) Gains from Investment Securities (2010 - 2026)
Precision Optics Corporation (POCI) reported Gains from Investment Securities of $187096.0 for Q1 2026, up 64.52% year-over-year from $113720.0 in Q1 2025, and up 144.55% quarter-over-quarter from $76507.0 in Q4 2025.
Precision Optics Corporation (POCI) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has 17 years of Gains from Investment Securities data on file, last reported at $187096.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $187096.0, up 64.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $187096.0 (up 64.52% YoY), and the FY2025 annual result was $1.6 million, up 55578.19% from the prior year.
- Gains from Investment Securities advanced to $187096.0 in Q1 2026 per POCI's latest filing, from $76507.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.3 million in Q3 2024 and troughed at $307.0 in Q1 2023.
- A 5-year average of $133463.2 and a median of $20000.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities plunged 99.04% in 2023, then soared 33130.9% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $5000.0 in 2022, then dropped by 0.02% to $4999.0 in 2023, then surged by 250.07% to $17500.0 in 2024, then jumped by 337.18% to $76507.0 in 2025, then jumped by 144.55% to $187096.0 in 2026.
- Business Quant data shows POCI's Gains from Investment Securities at $187096.0 in Q1 2026, $76507.0 in Q4 2025, and $133650.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Precision Optics Corporation | 44.43 Mn | 33.75 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,096.00 |
| Mar 31, 2026 | 187,096.00 |
| Dec 31, 2025 | 76,507.00 |
| Dec 31, 2025 | 76,507.00 |
| Jun 30, 2025 | 133,650.00 |
| Jun 30, 2025 | 133,650.00 |
| Mar 31, 2025 | 113,720.00 |
| Mar 31, 2025 | 113,720.00 |
| Dec 31, 2024 | 17,500.00 |
| Dec 31, 2024 | 17,500.00 |
| Sep 30, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 2,916.00 |
| Jun 30, 2024 | 2,916.00 |
| Mar 31, 2024 | 4,999.00 |
| Mar 31, 2024 | 4,999.00 |
| Dec 31, 2023 | 4,999.00 |
| Dec 31, 2023 | 4,999.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |